Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kristina T. Carm"'
Autor:
Susanne G. Kidd, Mari Bogaard, Kristina T. Carm, Anne Cathrine Bakken, Aase M. V. Maltau, Marthe Løvf, Ragnhild A. Lothe, Karol Axcrona, Ulrika Axcrona, Rolf I. Skotheim
Publikováno v:
Molecular Oncology, Vol 16, Iss 15, Pp 2810-2822 (2022)
Prognostic biomarkers for prostate cancer are needed to improve prediction of disease course and guide treatment decisions. However, biomarker development is complicated by the common multifocality and heterogeneity of the disease. We aimed to determ
Externí odkaz:
https://doaj.org/article/d1796a30178449a8b88e3d28a658aced
Autor:
Susanne G. Kidd, Kristina T. Carm, Mari Bogaard, Linn Guro Olsen, Anne Cathrine Bakken, Marthe Løvf, Ragnhild A. Lothe, Karol Axcrona, Ulrika Axcrona, Rolf I. Skotheim
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 6, Pp 634-641 (2021)
In primary prostate cancer, the common multifocality and heterogeneity are major obstacles in finding robust prognostic tissue biomarkers. The long noncoding RNA SCHLAP1 has been suggested, but its prognostic value has not been investigated in the co
Externí odkaz:
https://doaj.org/article/3110ba50953240c993880c96d1b7d187
Autor:
Jonas M. Strømme, Bjarne Johannessen, Susanne G. Kidd, Mari Bogaard, Kristina T. Carm, Xiaokang Zhang, Anita Sveen, Anthony Mathelier, Ragnhild A. Lothe, Ulrika Axcrona, Karol Axcrona, Rolf I. Skotheim
Publikováno v:
Cancer Gene Therapy. 29:1276-1284
Autor:
Kristina T. Carm, Bjarne Johannessen, Mari Bogaard, Anne Cathrine Bakken, Aase V. Maltau, Andreas M. Hoff, Ulrika Axcrona, Karol Axcrona, Ragnhild A. Lothe, Rolf I. Skotheim
Primary prostate cancer shows a striking intraorgan molecular heterogeneity, with multiple spatially separated malignant foci in the majority of patients. Metastatic prostate cancer, however, typically reveals more homogenous molecular profiles, sugg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9118c44bbf7bcf5bf61ce595a7ffcf9
http://hdl.handle.net/10852/99158
http://hdl.handle.net/10852/99158
Autor:
Jonas M, Strømme, Bjarne, Johannessen, Susanne G, Kidd, Mari, Bogaard, Kristina T, Carm, Xiaokang, Zhang, Anita, Sveen, Anthony, Mathelier, Ragnhild A, Lothe, Ulrika, Axcrona, Karol, Axcrona, Rolf I, Skotheim
Publikováno v:
Cancer gene therapy. 29(8-9)
The majority of prostate cancer patients are diagnosed with multiple primary malignant foci. The distinct foci are exceptionally heterogeneous with regard to DNA mutations, but whether this is recapitulated at the transcriptome level remains unknown.